ROCHE HOLDING AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320 USD | +6.67% |
|
+5.96% | +2.89% |
| 06:25am | Roche Receives Canadian Approval for Early-stage Lung Cancer Treatment | MT |
| Jul. 15 | ROCHE HOLDINGS AG : Sell rating from Goldman Sachs | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 848B | ||||||
| 627B | ||||||
| 363B | ||||||
| 318B | ||||||
| 299B |
